SplunK(NASDAQ:SPLK) Q4 2023 revenues of $1.251 billion, up 39% year-over-year

/ / Technology /

March 1, 2023 – Splunk Inc. (NASDAQ: SPLK), the cybersecurity and observability leader, today announced results for its fiscal fourth quarter and full year ended January 31, 2023. Splunk Inc. (NASDAQ: SPLK) reported fiscal Q4 net income per diluted share was $1.44,Analysts surveyed by Capital IQ expected $0.13 a share. Revenue for the quarter ended Jan. 31 was $1.25 billion, Analysts polled by Capital IQ expected $1.07 billion. For fiscal Q1 2024, which ends on April 30, revenue is expected to be between $710 million and $725 million versus consensus estimates of $803.4 million. For fiscal 2024 ending on January 31, 2024, the company expects revenue in the range of $3.85 billion and $3.9 billion versus consensus estimates of $4.01 billion. Fourth Quarter 2023 Financial Highlights Total revenues were $1.251 billion, an increase of 39% year-over-year. GAAP operating margin was 21.3%; Non-GAAP operating margin was 37.9%。 GAAP net income was $269 […]

SplunK(NASDAQ:SPLK) Q4 2023 revenues of $1.251 billion, up 39% year-over-year Read Post »

Ford Motor Co (NYSE:F): vehicle sales volume in the US rose by 21.9% year over year in February to 157,606 vehicles

/ / Consumer Discretionary /

Ford Motor Co (NYSE:F) said vehicle sales volume in the US rose by 21.9% year over year in February to 157,606 vehicles. US internal combustion sales increased 20.5% year over year in February to 144,926 units, while US electric vehicle sales were 68.1% higher at 3,523 units and hybrid vehicle sales rose 32.9% to 9,157 units, the company said.

Ford Motor Co (NYSE:F): vehicle sales volume in the US rose by 21.9% year over year in February to 157,606 vehicles Read Post »

Bernstein: Tesla’s (NASDAQ:TSLA) “Big Picture 3” lacks detail and gives it an “underperform” rating

/ / Consumer Discretionary / ,

Bernstein said Tesla’s (NASDAQ:TSLA) “Master Plan Part 3” announced at Wednesday’s investor event day looks at the long term but lacks details. The bank noted that Musk’s “grand chapter 3” is not so much Tesla’s roadmap as a hope for widespread electrification; Management updates, while informative, are not necessarily linear. As part of a larger vision, Tesla makes no mention of Boring Company and SpaceX, and rarely mentions of Tesla’s own solar business. Most importantly, Tesla did not provide more information about its upcoming lower-priced next-generation car, the bank noted. The bank has an “underperform” rating on Tesla’s stock and a $150 price target.

Bernstein: Tesla’s (NASDAQ:TSLA) “Big Picture 3” lacks detail and gives it an “underperform” rating Read Post »

Macy’s (NYSE:M) Q4 2022 Net sales of $8.3 billion, down 4.6% year-over-year

/ / Consumer Discretionary /

March 2, 2023 — Macy’s, Inc. (NYSE: M) today reported financial results for the fourth quarter and fiscal 2022 and provided fiscal 2023 guidance. Macy’s (NYSE:M)  reported fiscal Q4 adjusted earnings  of $1.88 per diluted share,Analysts polled by Capital IQ expected $1.59. Net sales for the quarter ended Jan. 28 were $8.26 billion, Analysts surveyed by Capital IQ expected $8.27 billion. For fiscal 2023, the company is expecting adjusted earnings of $3.67 to $4.11 per diluted share on net sales of $23.7 billion to $24.2 billion. Analysts surveyed by Capital IQ are expecting earnings of $4.17 on sales of $24.49 billion. Fourth Quarter 2022 Highlights Diluted earnings per share of $1.83 and Adjusted diluted earnings per share of $1.88, This compares to diluted earnings per share of $2.44 and Adjusted diluted earnings per share of $2.45 in the fourth quarter of 2021. This compares to diluted earnings per share of

Macy’s (NYSE:M) Q4 2022 Net sales of $8.3 billion, down 4.6% year-over-year Read Post »

Macy’s (NYSE:M) expects adjusted earnings per share of $3.67 to $4.11 this year, compared with a market estimate of $3.82

/ / Consumer Discretionary /

Macy’s (NYSE:M) expects net sales of $23.7 billion to $24.2 billion this year, compared with a market estimate of $24.32 billion, and an adjusted earnings per share of $3.67 to $4.11, compared with a market estimate of $3.82.

Macy’s (NYSE:M) expects adjusted earnings per share of $3.67 to $4.11 this year, compared with a market estimate of $3.82 Read Post »

Salesforce (NYSE:CRM) Q4 2023 revenue of $8.38 billion, up 14% year-over-year

/ / Technology /

March 1, 2023 – Salesforce (NYSE: CRM), the global leader in CRM, today announced results for its fourth quarter and full fiscal year ended January 31, 2023. Salesforce (NYSE: CRM) reported fiscal Q4 diluted earnings  of $1.68,Analysts polled by Capital IQ expected $1.36. Revenue for the quarter was $8.38 billion, Analysts surveyed by Capital IQ expected $7.99 billion. The company said it expects Q1 adjusted earnings of $1.60 to $1.61 on revenue of $8.16 billion to $8.18 billion. Analysts polled by Capital IQ are looking for adjusted earnings of $1.32 on revenue of $8.03 billion. The company said it expects full fiscal 2024 adjusted earnings of $7.12 to $7.14 on revenue of $34.5 billion to $34.7 billion. Analysts surveyed by Capital IQ are expecting adjusted earnings of $5.87 on revenue of $34.13 billion. Fourth Quarter Revenue of $8.38 Billion, up 14% Year-Over-Year. Revenue: Total fourth quarter revenue was $8.38 billion, an

Salesforce (NYSE:CRM) Q4 2023 revenue of $8.38 billion, up 14% year-over-year Read Post »

Snowflake(NYSE:SNOW) Q4 2023 revenue was $589.0 million,up 53% year-over-year

/ / Technology /

March 1, 2023 – Snowflake (NYSE: SNOW), the Data Cloud company, today announced financial results for its fourth quarter and full-year of fiscal 2023, ended January 31, 2023. Snowflake (NYSE: SNOW) reported non-GAAP Q4 net income of $0.15 per share, Analysts polled by Capital IQ, on average, had been expecting the data-management company to earn $0.05 per share, excluding one-time items. Revenue rose 54% year-over-year to $555.3 million during the three months ended Jan. 31. The analyst mean had been expecting $575.5 million in Q4 revenue. Looking forward, the company is projecting between $568 million to $573 million in Q1 revenue. The Street view is expecting $714.9 million in revenue for the three months ending April 30. Revenue for the quarter was $589.0 million, representing 53% year-over-year growth. Product revenue for the quarter was $555.3 million, representing 54% year-over-year growth. Remaining performance obligations were $3.7 billion, representing 38% year-over-year growth. Net revenue

Snowflake(NYSE:SNOW) Q4 2023 revenue was $589.0 million,up 53% year-over-year Read Post »

Okta Inc.(NASDAQ:OKTA) Q4 2023 revenue was $510 million, up 33% year-over-year

/ / Technology /

March 1, 2023 – Okta, Inc. (Nasdaq: OKTA), the leading independent identity provider, today announced financial results for its fourth quarter and fiscal year ended January 31, 2023. Okta, Inc. (Nasdaq: OKTA) reported fiscal Q4 non-GAAP diluted earnings of $0.30 per share, Analysts polled by Capital IQ expected $0.09. Revenue for the quarter that ended Jan. 31 was $510 million,Analysts surveyed by Capital IQ expected $489.6 million. The company said it expects Q1 non-GAAP earnings of $0.11 to $0.12 on revenue of $509 million to $511 million, versus the average analyst estimates compiled by Capital IQ for a loss of $0.01 per share on sales of $498.3 million, respectively. The company expects full-year fiscal 2024 non-GAAP earnings of $0.74 to $0.79 on revenue of $2.16 billion to $2.17 billion, compared with the average analyst estimates compiled by Capital IQ of $0.31 a share on revenue of $2.17 billion, respectively. Fourth Quarter Fiscal 2023

Okta Inc.(NASDAQ:OKTA) Q4 2023 revenue was $510 million, up 33% year-over-year Read Post »

Eli Lilly cuts insulin drug prices by 70%

/ / Health Care /

Eli Lilly announced Wednesday that a 70 percent price cut for its two best-selling insulin products, Humalog and Humulin, will take effect in the fourth quarter. Lilly also said it would reduce the list price of unbranded insulin from $82 to $25 per vial starting May 1, the lowest price for insulin taken by diabetics at mealtime and lower than Lilly’s 1999 Humalog sticker price. Eli Lilly also plans to improve a program that limits out-of-pocket costs to $35 a month for patients.

Eli Lilly cuts insulin drug prices by 70% Read Post »

Kohl’s (NYSE:KSS) Q4 2022 net sales of $5.8 billion,down 7.2% year-over-year

/ / Consumer Discretionary /

March 1, 2023— Kohl’s Corporation (NYSE:KSS) today reported results for the quarter and year ended January 28, 2023. Kohl’s Corporation (NYSE:KSS) reported a fiscal Q4 adjusted loss  of $2.49 per diluted share, Analysts polled by Capital IQ forecast normalized earnings of $0.97 per share. Net sales for the quarter ended Jan. 28 were $5.78 billion, Analysts surveyed by Capital IQ projected $6.03 billion. The department store chain operator’s Q4 comparable sales fell 6.6%. Analysts polled by Capital IQ expected a year-over-year decrease of 4.1%. Kohl’s said it expects fiscal 2023 earnings, excluding non-recurring charges, of $2.10 to $2.70 per share. Analysts polled by Capital IQ are expecting normalized earnings of $2.99 per share. Net sales for the year are expected to fall 2% to 4%, the company said. Analysts polled by Capital IQ are looking for net sales of $17.54 billion. Fourth Quarter 2022 Results Net sales decreased 7.2% year-over-year, to $5.8 billion,

Kohl’s (NYSE:KSS) Q4 2022 net sales of $5.8 billion,down 7.2% year-over-year Read Post »

Scroll to Top